Literature DB >> 27822407

Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation.

Juliana Carvalho Santos1, Marcelo Lima Ribeiro2, Luis Otávio Sarian1, Manoela Marques Ortega2, Sophie Françoise Derchain1.   

Abstract

Breast cancer is the most common and fatal type of cancer in women worldwide due to the metastatic process and resistance to treatment. Despite advances in molecular knowledge, little is known regarding resistance to chemotherapy. One highlighted aspect is the DNA damage response (DDR) pathway that is activated upon genotoxic damage, controlling the cell cycle arrest or DNA repair activation. Recently, studies have showed that cancer stem cells (CSCs) could promote chemoresistance through DDR pathway. Furthermore, it is known that the epithelial-mesenchymal transition (EMT) can generate cells with CSCs characteristics and therefore regulate the chemoresistance process. The exosomes are microvesicles filled with RNAs, proteins and microRNAs (miRNAs) that can be released by many cell types, including tumor cells and CSCs. The exosomes content may be cell-to-cell transferable and it could control a wide range of pathways during tumor development and metastasis. A big challenge for modern medicine is to determine the reasons why patients do not respond to chemotherapy treatments and also guide the most appropriate therapy for each one. Considering that the CSCs are able to stimulate the formation of a more aggressive tumor phenotype with migration and metastasis ability, resistance to treatment and disease recurrence, as well as few studies capable to determine clearly the interaction of breast CSCs with its microenvironment, the present review summarize the possibility that exosomes-mediate miRNAs transfer and regulate chemoresistance in breast tumor cells and CSCs, to clarify the complexity of breast cancer progression and therapy.

Entities:  

Keywords:  Breast cancer; chemoresistance; exosomes; microRNAs

Year:  2016        PMID: 27822407      PMCID: PMC5088281     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  109 in total

1.  Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer.

Authors:  Dong-Xu He; Xiao-Ting Gu; You-Ran Li; Li Jiang; Jian Jin; Xin Ma
Journal:  FEBS J       Date:  2014-09-30       Impact factor: 5.542

2.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

Review 3.  Mechanism-based cancer therapy: resistance to therapy, therapy for resistance.

Authors:  P Ramos; M Bentires-Alj
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

4.  The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.

Authors:  Xiaohong Xie; Yuanyuan Hu; Leilai Xu; Yongqing Fu; Jue Tu; Hong Zhao; Shuo Zhang; Ri Hong; Xidong Gu
Journal:  Tumour Biol       Date:  2015-04-17

5.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

Review 6.  Genes causing inherited cancer as beacons to identify the mechanisms of chemoresistance.

Authors:  Per Eystein Lønning
Journal:  Trends Mol Med       Date:  2004-03       Impact factor: 11.951

7.  Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas.

Authors:  Ashley Cimino-Mathews; Andrea P Subhawong; Hillary Elwood; Hind Nassar Warzecha; Rajni Sharma; Ben Ho Park; Janis M Taube; Peter B Illei; Pedram Argani
Journal:  Hum Pathol       Date:  2012-12-20       Impact factor: 3.466

Review 8.  Exosomes in cancer: small particle, big player.

Authors:  Xu Zhang; Xiao Yuan; Hui Shi; Lijun Wu; Hui Qian; Wenrong Xu
Journal:  J Hematol Oncol       Date:  2015-07-10       Impact factor: 17.388

9.  MiR-133a Is Functionally Involved in Doxorubicin-Resistance in Breast Cancer Cells MCF-7 via Its Regulation of the Expression of Uncoupling Protein 2.

Authors:  Yuan Yuan; Yu Feng Yao; Sai Nan Hu; Jin Gao; Li-Li Zhang
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

10.  MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.

Authors:  Lily Boo; Wan Yong Ho; Norlaily Mohd Ali; Swee Keong Yeap; Huynh Ky; Kok Gan Chan; Wai Fong Yin; Dilan Amila Satharasinghe; Woan Charn Liew; Sheau Wei Tan; Han Kiat Ong; Soon Keng Cheong
Journal:  Int J Biol Sci       Date:  2016-02-12       Impact factor: 6.580

View more
  24 in total

Review 1.  Extracellular vesicle-mediated transport of non-coding RNAs between stem cells and cancer cells: implications in tumor progression and therapeutic resistance.

Authors:  Muhammad Nawaz
Journal:  Stem Cell Investig       Date:  2017-10-24

2.  Tumor microenvironment heterogeneity: challenges and opportunities.

Authors:  F Runa; S Hamalian; K Meade; P Shisgal; P C Gray; J A Kelber
Journal:  Curr Mol Biol Rep       Date:  2017-10-30

3.  miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells.

Authors:  Dengfeng Li; Jiashu Hu; Hongming Song; Hui Xu; Chengyang Wu; Bingkun Zhao; Dan Xie; Tianqi Wu; Junyong Zhao; Lin Fang
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

4.  Exercise-Induced Circulating microRNAs: Potential Key Factors in the Control of Breast Cancer.

Authors:  Guilherme Defante Telles; Miguel Soares Conceição; Felipe Cassaro Vechin; Cleiton Augusto Libardi; Marcelo Alves da Silva Mori; Sophie Derchain; Carlos Ugrinowitsch
Journal:  Front Physiol       Date:  2022-06-16       Impact factor: 4.755

Review 5.  Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications.

Authors:  Jiangdong Qiu; Gang Yang; Mengyu Feng; Suli Zheng; Zhe Cao; Lei You; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Mol Cancer       Date:  2018-01-05       Impact factor: 27.401

Review 6.  The molecular mechanisms of chemoresistance in cancers.

Authors:  Hua-Chuan Zheng
Journal:  Oncotarget       Date:  2017-07-06

7.  MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1.

Authors:  Yaming Li; Yiran Liang; Yuting Sang; Xiaojin Song; Hanwen Zhang; Ying Liu; Liyu Jiang; Qifeng Yang
Journal:  Cell Death Dis       Date:  2018-01-11       Impact factor: 8.469

8.  Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2.

Authors:  Hai-Li Lang; Guo-Wen Hu; Bo Zhang; Wei Kuang; Yong Chen; Lei Wu; Guo-Hai Xu
Journal:  Oncol Rep       Date:  2017-06-22       Impact factor: 3.906

Review 9.  Tumor-derived exosomes in colorectal cancer progression and their clinical applications.

Authors:  Jianbiao Zhou; Xiao-Lan Li; Zhi-Rong Chen; Wee-Joo Chng
Journal:  Oncotarget       Date:  2017-08-10

Review 10.  Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic Applications.

Authors:  Lorenzo F Sempere; Jessica Keto; Muller Fabbri
Journal:  Cancers (Basel)       Date:  2017-06-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.